Does aspirin prevent cardiovascular events and major bleeding in older adults for primary prevention?
This is an editorial discussing the extended follow-up of the ASPREE trial regarding aspirin for primary prevention in older adults.
This editorial refers to ‘Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial’, by R. Wolfe et al.,
Baigent et al. (Fri,) studied this question.